Matthew Sykes
Stock Analyst at Goldman Sachs
(0)
# 3951
Out of 5,218 analysts
216
Total ratings
50.00%
Success rate
-2.40%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
Nautilus Biotechnolo... | Downgrades: Sell | 3 2 | 1.96 | -10.71% | 5 | Dec 5, 2024 | |
Maravai LifeSciences | Downgrades: Sell | 7 5 | 5.67 | -25.04% | 10 | Dec 5, 2024 | |
Veracyte | Downgrades: Neutral | 38 37 | 43.21 | -14.37% | 5 | Dec 5, 2024 | |
Bruker | Upgrades: Neutral | 60 60 | 57.61 | 4.15% | 4 | Dec 5, 2024 | |
Guardant Health | Maintains: Strong Buy | 32 36 | 34.67 | 3.84% | 11 | Nov 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 75 65 | 61.38 | 5.9% | 12 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 280 250 | 199.24 | 25.48% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 54 70 | 75.44 | -7.21% | 10 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 16 14 | 14.18 | -1.27% | 6 | Oct 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 370 280 | 208.16 | 34.51% | 2 | Oct 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 125 140 | 166.11 | -15.72% | 12 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 26 35 | 22.94 | 52.57% | 9 | Oct 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 26 23 | 19.78 | 16.28% | 2 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 290 250 | 190.3 | 31.37% | 2 | Aug 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 225 250 | 235.01 | 6.38% | 4 | Jul 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 45 55 | 47.54 | 15.69% | 9 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 23 7 | 20 | -67.5% | 11 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 35 24 | 10.69 | 124.51% | 13 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1150 1300 | 1278.78 | 1.66% | 5 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 32 12 | 9.41 | 27.52% | 6 | Jul 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 7 3 | 1.96 | 27.55% | 3 | Apr 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 550 640 | 527.13 | 21.41% | 4 | Apr 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 9 10 | 6.19 | 61.55% | 8 | Feb 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 17 19 | 17.72 | 7.22% | 5 | Feb 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 28 31 | 14.4 | 115.28% | 9 | Jan 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 23 26 | 22.32 | 16.49% | 5 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 128 145 | 139.07 | 4.26% | 4 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Buy | n/a | n/a | n/a | 3 | Dec 7, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 6 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 120 105 | 115.62 | -9.19% | 1 | Oct 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 1 1 | n/a | n/a | 8 | Oct 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 1 1 | n/a | n/a | 2 | May 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 16 18 | n/a | n/a | 5 | Feb 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 3 1 | n/a | n/a | 2 | Dec 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 200 175 | n/a | n/a | 3 | Jul 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 120 60 | n/a | n/a | 4 | Apr 19, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | n/a | n/a | 4 | Apr 13, 2022 |